Article | July 25, 2017

Autologous Cell Therapies At A Crossroads With The FDA: What Can You Do to Help?

Source: Finesse, part of Thermo Fisher Scientific
Autologous Cell Therapies At A Crossroads With The FDA: What Can You Do to Help?

Regulatory controls on local collection and processing of autologous cells present a major challenge to clinics that want to provide individualized therapies onsite. What does the pharmaceutical industry need to know — and, more importantly, do — to overcome it?

Finesse, part of Thermo Fisher Scientific